Advertisement
Screener

Apyx Medical Corp (APYX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

2.4 / 5 stars · 23/48 Roast Me

Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

Apyx Medical Corp (APYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $4.00 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2024-03-21

  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2023 was $4.00, a 35.79% decline from fiscal 2022.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $6.23, a 19.58% increase from fiscal 2021.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2021 was $5.21, a 15.01% increase from fiscal 2020.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2020 was $4.53, a 96.10% increase from fiscal 2019.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month
2023-12-31$4.00
10-K · filed 2024-03-21
2022-12-31$6.23
10-K · filed 2023-03-16
2021-12-31$5.21
10-K · filed 2022-03-17
2020-12-31$4.53
10-K · filed 2021-03-31
2019-12-31$2.31
10-K · filed 2020-03-31
2018-12-31$2.10
10-K · filed 2019-03-14
2017-12-31$1.95
10-K · filed 2018-03-13
2016-12-31$1.75
10-K · filed 2017-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Microbot Medical Inc. (MBOT)$0.089B-7.97
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
LENSAR, Inc. (LNSR)United States$0.087B2.02
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
Pulmonx Corp (LUNG)United States$0.082B-1.16
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Lucid Diagnostics Inc. (LUCD)United States$0.170B
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39